The leading stocks for heart disease include:
Lanfan Medical
Judging from the compound growth rate of net profit in the past three years, the compound growth rate of net profit in the past three years is 258.66 , with a maximum of 1.758 billion yuan in 2020. Lanfan Medical is a leading company in the global PVC glove industry. Its annual production, sales and market share of PVC gloves rank first in the world.
The company acquired NVTAG in June 2020 and successfully entered the field of structural heart disease. In the past 7 trading days, Lanfan Medical has fallen on 3 days, with the overall price falling by 0.61 during the period, with the highest price being 13.53 yuan and the lowest price being 13.19 yuan. Compared with seven trading days ago, Lanfan Medical's market value fell by 80.5643 million yuan.
Sino Medical
Judging from the compound growth of net profit in the past three years, the compound growth of net profit in the past three years was -75.02, with the highest reaching 90.0378 million yuan in 2019.
Sano Medical has fallen by 2.77 points overall in the past seven trading days, with the highest price at 6.63 yuan and the lowest price at 6.73 yuan, with a total trading volume of 18.5754 million lots. Down -29.43 in 2022.